Furthermore, it has been suggested that both the mRNA expression and plasma levels of SELENOP were significantly lower among rs7579 CC than T allele carriers (16, 17), and decreased plasma SELENOP was related with increased risks of several dyslipidemia-related diseases, including metabolic syndrome, cerebrovascular events, and cardiovascular disease (33–35). The gene discussed is SELENOP; the disease is metabolic syndrome.